[go: up one dir, main page]

MX2018002983A - Suspensión antiviral potencializadora para tratamiento de fibras y su metodo de preparación. - Google Patents

Suspensión antiviral potencializadora para tratamiento de fibras y su metodo de preparación.

Info

Publication number
MX2018002983A
MX2018002983A MX2018002983A MX2018002983A MX2018002983A MX 2018002983 A MX2018002983 A MX 2018002983A MX 2018002983 A MX2018002983 A MX 2018002983A MX 2018002983 A MX2018002983 A MX 2018002983A MX 2018002983 A MX2018002983 A MX 2018002983A
Authority
MX
Mexico
Prior art keywords
fibres
preparation
treatment
suspension
antiviral
Prior art date
Application number
MX2018002983A
Other languages
English (en)
Inventor
Alonso Torres Avalos Gerardo
Ariadna Lozano Gonzalez Edith
Original Assignee
Inst Tecnologico Jose Mario Molina Pasquel Y Henriquez
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Tecnologico Jose Mario Molina Pasquel Y Henriquez filed Critical Inst Tecnologico Jose Mario Molina Pasquel Y Henriquez
Priority to MX2018002983A priority Critical patent/MX2018002983A/es
Priority to PCT/MX2018/000034 priority patent/WO2019172739A1/es
Publication of MX2018002983A publication Critical patent/MX2018002983A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/243Platinum; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/28Compounds containing heavy metals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/28Compounds containing heavy metals
    • A61K31/30Copper compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/28Compounds containing heavy metals
    • A61K31/315Zinc compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/28Compounds containing heavy metals
    • A61K31/32Tin compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/30Zinc; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/32Manganese; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/34Copper; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/26Aluminium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/27Zinc; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/28Zirconium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Birds (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

La presente invención consiste en una suspensión antiviral para tratamiento de fibras que comprende por lo menos una sal orgánica de un metal mono, di o trivalente con actividad antiviral suspendida en una solución reguladora del pH ácido; el proceso para obtenerla; y el proceso para obtener fibras antivirales empleando dicha suspensión antiviral.
MX2018002983A 2018-03-09 2018-03-09 Suspensión antiviral potencializadora para tratamiento de fibras y su metodo de preparación. MX2018002983A (es)

Priority Applications (2)

Application Number Priority Date Filing Date Title
MX2018002983A MX2018002983A (es) 2018-03-09 2018-03-09 Suspensión antiviral potencializadora para tratamiento de fibras y su metodo de preparación.
PCT/MX2018/000034 WO2019172739A1 (es) 2018-03-09 2018-04-09 Suspensión antiviral potencializadora para tratamiento de fibras y su método de preparación

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2018002983A MX2018002983A (es) 2018-03-09 2018-03-09 Suspensión antiviral potencializadora para tratamiento de fibras y su metodo de preparación.

Publications (1)

Publication Number Publication Date
MX2018002983A true MX2018002983A (es) 2019-09-10

Family

ID=67847349

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018002983A MX2018002983A (es) 2018-03-09 2018-03-09 Suspensión antiviral potencializadora para tratamiento de fibras y su metodo de preparación.

Country Status (2)

Country Link
MX (1) MX2018002983A (es)
WO (1) WO2019172739A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117684393A (zh) * 2023-10-19 2024-03-12 浙江金海高科股份有限公司 一种具有抗病毒性能的干用纤维材料及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6475526B1 (en) * 2001-06-05 2002-11-05 Jeffrey B. Smith Zinc containing compositions for anti-viral use
DE102005020327A1 (de) * 2005-04-30 2006-11-09 Multibind Biotec Gmbh Dekontaminationslösungen und deren Verwendung zur Denaturierung, Modifikation, Degradation, Solubilisierung und Entfernung von Proteinen, Nukleinsäuremolekülen und Mikroorganismen von Oberflächen
DE102006058790A1 (de) * 2006-12-12 2008-06-19 Sanitized Ag Verfahren zur antimikrobiellen Ausrüstung von Textilien und Faser
DE102007030103A1 (de) * 2007-06-28 2009-01-02 Bode Chemie Gmbh & Co. Kg Verwendung einer synergistischen Zusammensetzung als therapeutisches oder kosmetisches Mittel
DE102008064481A1 (de) * 2008-12-18 2010-08-12 Bode Chemie Gmbh Kombinierte Desinfektions- und Dekontaminationsmittel mit erhöhter Wirksamkeit
MA41021A (fr) * 2014-11-25 2017-10-03 Cms Tech Inc Compositions antimicrobiennes à base de cuivre et leur utilisation dans le traitement de produits alimentaires et de surfaces
RU2743529C1 (ru) * 2015-09-29 2021-02-19 Текуро Медикал Гмбх Стабилизированные антисептические препараты

Also Published As

Publication number Publication date
WO2019172739A1 (es) 2019-09-12

Similar Documents

Publication Publication Date Title
MX357216B (es) Postratamiento de un material zeolitico.
PH12018500664A1 (en) Anti-lag3 antibodies and uses thereof
CL2015003355A1 (es) Derivados del bipirazol como inhibidores jak
MY192888A (en) Dna alkylating agents
PH12019501425A1 (en) Human antibodies to s. aureus hemolysin a toxin
WO2016100261A3 (en) Method of treating cancer with cgamp or cgasmp
TN2014000058A1 (en) A Novel 1,2,3,4-Tetrahydroquinoline Derivative Useful for the Treatment of Diabetes
MX2017007816A (es) Proceso para mejorar porciones y productos musculares.
SG11201811835YA (en) Diorganylphosphinic acid salts, method for the production thereof and the use thereof
NZ704092A (en) Ph adjusted pulse protein product
EA201890884A1 (ru) Способ и композиции для нежелательных и аномальных мышечных сокращений
NZ702178A (en) Lingo-2 antagonists for treatment of conditions involving motor neurons
EP3487985C0 (en) METHOD FOR PREVENTING OR TREATING MOVEMENT DISORDERS USING LACTIC BACTERIA
PH12014502193B1 (en) Multiple uses of amine salts for industrial water treatment
WO2020209988A3 (en) Diverse marker panel for ptsd diagnosis and treatment
PH12017502069A1 (en) Method for treating coffee rust, citrus black spot, citrus scab and banana black sigatoka diseases
MX2022001703A (es) Metodos para producir estiercol tratado.
PH12022550486B1 (en) Pathogenic control compositions and methods
MX2018002983A (es) Suspensión antiviral potencializadora para tratamiento de fibras y su metodo de preparación.
EP4397752A3 (en) Methods for obtaining induced smooth muscle cells
PH12017500998A1 (en) Treatment of ocular conditions using progenitor cells
MA43069A (fr) Procédé pour lutter contre des mauvaises herbes résistantes ou tolérantes aux herbicides
SG11201803868RA (en) Hydroponic culture method for plant in high salinity environment
EP3522827A4 (en) DEVICES AND METHODS FOR TREATING CONGESTIVE HEART FAILURE, ASCITES, AND OTHER DISORDERS RELATED TO EXCESS BODY FLUID
PH12020551455A1 (en) Method for controlling harmful insects